Advertisement
Other Topics

Abstract A169: NY-ESO-1 protein cancer vaccine with TLR 3 and 4 agonists

Tomohira Takeoka, Hirotsugu Nagase, Yasuhiro Miyazaki, Tsuyoshi Takahashi, Yukinori Kurokawa, Tomoki Makino, Makoto Yamasaki, Shuji Takiguchi, Masaki Mori, Yuichiro Doki and Hisashi Wada
DOI: 10.1158/2326-6074.CRICIMTEATIAACR15-A169 Published January 2016

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: January 2016 to February 2021

AbstractFull-text HTMLPDF
Total68700

Cited By

Article Information

Volume 4, Issue 1 Supplement, pp. A169

DOI 
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-A169
Published By 
American Association for Cancer Research
Print ISSN 
2326-6066
Online ISSN 
2326-6074
Copyright & Usage 
©2016 American Association for Cancer Research.

Author Information

  1. Tomohira Takeoka1,
  2. Hirotsugu Nagase1,
  3. Yasuhiro Miyazaki1,
  4. Tsuyoshi Takahashi1,
  5. Yukinori Kurokawa1,
  6. Tomoki Makino1,
  7. Makoto Yamasaki1,
  8. Shuji Takiguchi1,
  9. Masaki Mori1,
  10. Yuichiro Doki1, and
  11. Hisashi Wada2
  1. 1Department of Gastroenterological Surgery, Osaka University, Suita, Japan,
  2. 2Department of Clinical Research in Tumor Immunology, Osaka University, Suita, Japan.
Back to top
Cancer Immunology Research: 4 (1 Supplement)
January 2016
Volume 4, Issue 1 Supplement

Sign up for alerts

Article Alerts
Email Article
Citation Tools
Abstract A169: NY-ESO-1 protein cancer vaccine with TLR 3 and 4 agonists
Tomohira Takeoka, Hirotsugu Nagase, Yasuhiro Miyazaki, Tsuyoshi Takahashi, Yukinori Kurokawa, Tomoki Makino, Makoto Yamasaki, Shuji Takiguchi, Masaki Mori, Yuichiro Doki and Hisashi Wada
Cancer Immunol Res January 1 2016 (4) (1 Supplement) A169; DOI: 10.1158/2326-6074.CRICIMTEATIAACR15-A169
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section

Advertisement